The National Institutes of Health's National Institute of Child Health and Human Development awarded an indefinite delivery contract to the University of Utah Office of Sponsored Projects Division to conduct clinical trials in support of contraceptive development. The multiple award IDV has a potential value of $5 million and a period of performance through July 2027. Under the IDV, the prime contractor will receive task orders to finalize protocols, obtain regulatory approvals, and commence...
The National Institutes of Health National Institute of Child Health and Human Development awarded an indefinite delivery contract to Essential Access Health to conduct clinical trials and develop protocols in support of the Contraceptive Development Program. The IDV has a potential value of $5 million and a period of performance through July 2027. Under the IDV, Essential Access Health has received two cost-no-fee delivery orders to date. The first, valued at $349,327, tasks the contractor to...
The National Institutes of Health National Institute of Child Health and Human Development awarded an indefinite delivery contract to Boston Medical Center Corporation to conduct clinical trials of contraceptive products and treatments for gynecologic conditions. The IDV has a potential value of $5 million and a period of performance through July 2027. Under the IDV, Boston Medical Center has received multiple task orders to advance specific products and services. A $126,095 order finalized...
The National Institutes of Health's National Institute of Child Health and Human Development awarded Emory University multiple contracts to support its Contraceptive Development Program. Under an indefinite delivery contract with a potential value of $5 million, Emory will conduct clinical trials of contraceptive products and treatments for gynecologic conditions from 2020-2027 on a task order basis. Two task orders were issued, the first for $94,652 to finalize the protocol and commence patient...
The National Institute of Child Health and Human Development (NICHD), part of the U.S. Department of Health and Human Services, awarded a $5,000,000 Indefinite Delivery Contract (IDC) to The Regents of the University of Colorado to conduct clinical trials for new contraceptive methods and treatments for gynecological conditions over a 7-year period ending in 2027. This IDC is part of NICHD's Contraceptive Development Program and Contraceptive Clinical Trials Network (CCTN), which aims to advance...
The National Institute of Child Health and Human Development (NICHD), a component of the National Institutes of Health (NIH), has awarded an Indefinite Delivery Contract (IDV) valued at $5,000,000 to the University of Cincinnati's Sponsored Research Services Division. This 7-year IDV facilitates the conduct of clinical trials related to contraceptive development, gynecologic conditions, and associated protocol development. Under this IDV, two task orders have been issued to the University of...
The National Institutes of Health's National Institute of Child Health and Human Development awarded an indefinite delivery contract to The Trustees of the University of Pennsylvania, doing business as Clinical Practices of the University of Pennsylvania. The contract has a potential value of $5,000,000 and period of performance through July 2027. Task orders issued to date include $92,034 for finalizing a clinical trial protocol and $103,767 to assist in developing new contraceptive products...
The National Institutes of Health's National Institute of Child Health and Human Development awarded Oregon Health & Science University an indefinite delivery contract with a potential value of $5,000,000 to conduct clinical trials in support of contraceptive development. Task orders issued against this contract include protocols for Phase 1 evaluation of the Ovaprene device ($181k), central laboratory services for pharmacokinetic analysis of levonorgestrel butanoate ($349k), and...
The National Institutes of Health National Institute of Child Health and Human Development awarded a multiple award indefinite delivery contract to The Johns Hopkins University to conduct clinical research in support of contraceptive development and trials. With a potential value of $5,000,000 over a period from August 2020 through July 2027, the IDV enables task orders for protocol review, development assistance, and activities associated with the Contraceptive Clinical Trials Network...
The National Institutes of Health's National Institute of Child Health and Human Development awarded multiple indefinite delivery contracts to establish the Contraceptive Clinical Trials Network for female clinical research sites. Magee-Womens Research Institute and Foundation was awarded contracts under this vehicle to conduct various clinical trials. Two delivery orders were issued to Magee-Womens Research Institute and Foundation under the Network's contracts. The first was for...
The National Institutes of Health National Institute of Child Health and Human Development awarded a multiple award IDV to various contractors to conduct clinical trials in support of contraceptive development and the Contraceptive Clinical Trials Network for female sites. Task orders were issued to the University of California, Davis for protocol finalization and start-up of the Ovaprene vaginal device clinical trial, as well as to provide assistance with protocol review and development activities, collectively valued at $531,299 to be performed in Davis, California through July 2027.
The IDV aims to advance candidate contraceptives and treatments for conditions like endometriosis through phase I-IV clinical trials and protocol development tasked to contractors on an individual basis. Specifically, the originating solicitation sought capability statements from small businesses to organize and manage trials recruiting subjects for first-in-human and repeat dose safety/efficacy studies involving pharmacokinetic, pharmacodynamic, and hormonal assessments. No set-asides were applied. The National Institute of Child Health and Human Development Contraceptive Clinical Trials Network and Contraceptive Development Program aim to support bringing candidate methods through development and FDA approval processes.